Speech Therapy Practice EBITDA Valuation Multiples
How buyers price SLP clinics in the $1M–$5M revenue range — and what moves the multiple up or down.
Speech therapy practices in the lower middle market typically trade at 3.5x–6x EBITDA, reflecting strong demand from PE-backed therapy roll-ups and SBA-financed SLP buyers. Valuation hinges on owner independence, payer mix diversification, staff depth, and referral source durability. Practices with recurring school district contracts, low founder clinical involvement, and employed SLP teams command premium multiples, while Medicaid-heavy or founder-dependent clinics face meaningful discounts.
Speech Therapy Practice EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed / Founder-Dependent | $150K–$300K | 3.5x–4.0x | Owner performs 40%+ of billable hours, heavy Medicaid concentration, limited staff depth, or unresolved billing compliance exposure. |
| Stable / Owner-Operated | $300K–$600K | 4.0x–4.75x | 3–4 employed SLPs, moderate payer diversification, some owner clinical involvement, established local referral relationships. |
| Growing / Team-Based | $600K–$900K | 4.75x–5.5x | Owner largely administrative, 5+ SLPs, diversified payer mix, school contracts, documented referral pipelines, clean EHR and compliance history. |
| Premium / Platform-Ready | $900K+ | 5.5x–6.0x | Multi-location or telehealth capability, PE roll-up target, minimal owner clinical hours, recurring government contracts, strong retention metrics. |
What Drives Speech Therapy Practice Multiples
Owner Clinical Involvement
High Negative impactPractices where the founder generates more than 40% of billable revenue face steep discounts; buyers price in transition risk and potential patient attrition post-close.
Payer Mix Diversification
High Positive impactA balanced mix of private insurance, direct-pay, and school district contracts reduces reimbursement risk. Heavy Medicaid concentration compresses multiples due to rate volatility.
SLP Staff Depth and Retention
High Positive impactPractices with 3–5+ employed SLPs holding independent patient relationships signal scalability and reduce key-person risk, directly supporting premium valuations.
Referral Source Durability
Moderate Positive impactLong-standing school district contracts, ENT referrals, and pediatrician relationships tied to the practice entity — not the owner personally — are significant value drivers.
Billing Compliance and EHR Quality
Moderate Negative impactUnresolved insurance audit exposure, outdated EHR systems, or poor HIPAA documentation create escrow holdbacks or price reductions during due diligence.
Recent Market Trends
PE-backed therapy platform consolidation accelerated in 2022–2024, compressing cap rates and pushing quality practices toward the upper end of the 5x–6x range. SBA 7(a) financing remains the dominant acquisition structure for individual SLP buyers. SLP workforce shortages are simultaneously pressuring margins and making staff-stable practices scarcer and more valuable to acquirers.
Sample Speech Therapy Practice Transactions
Pediatric SLP clinic, Southeast U.S., 4 employed therapists, school district contracts, minimal owner caseload, diversified payer mix, clean compliance history.
$520,000
EBITDA
5.2x
Multiple
$2,704,000
Price
Single-location adult and pediatric practice, Midwest, owner performs 35% of billable hours, Medicaid-heavy payer mix, limited telehealth infrastructure.
$280,000
EBITDA
3.8x
Multiple
$1,064,000
Price
Multi-specialty outpatient therapy group with SLP division, 6 SLPs, two locations, recurring ENT and pediatrician referrals, strong waitlist demand.
$875,000
EBITDA
5.75x
Multiple
$5,031,250
Price
EBITDA Valuation Estimator
Get your Speech Therapy Practice business value range instantly
Industry: Speech Therapy Practice · Multiples based on 4.0x–4.75x (Stable / Owner-Operated)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect when selling my speech therapy practice?
Most SLP practices in the $1M–$5M revenue range sell at 3.5x–6x EBITDA. Your specific multiple depends on owner independence, staff depth, payer mix, and referral source durability.
Why does owner clinical involvement reduce the sale price of an SLP practice?
Buyers price in revenue-at-risk when the founder holds the patient relationships. Reducing your personal caseload below 25% of practice revenue before selling materially improves your multiple.
Do speech therapy practices qualify for SBA financing?
Yes. SLP practices are SBA 7(a) eligible. Most deals involve 10–20% buyer equity, an SBA loan covering the majority of the purchase price, and a short-term seller note.
How does Medicaid concentration affect my speech therapy practice valuation?
Heavy Medicaid reliance introduces reimbursement rate risk and administrative burden, which buyers discount. Practices with under 30% Medicaid revenue and strong private-pay or school contracts command higher multiples.
More Speech Therapy Practice Guides
Find Speech Therapy Practice businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required